NOVAVAX INC (NVAX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $73.04M | -64.0% |
| 2024 | $202.74M | -41.0% |
| 2023 | $343.77M | -61.9% |
| 2022 | $902.64M | — |
| 2021 | $0 | — |
| 2020 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $73.04M | -64.0% |
| 2024 | $202.74M | -41.0% |
| 2023 | $343.77M | -61.9% |
| 2022 | $902.64M | — |
| 2021 | $0 | — |
| 2020 | $0 | — |